e-learning
resources
Copenhagen 2005
Monday 19.09.2005
COPD - treatment II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhibition of reactive nitrogen species production in COPD airways: comparison between steroid and theophylline
T. Hirano, M. Nakanishi, M. Gohda, T. Yamagata, K. Fukui, K. Ueshima, K. Akamatsu, Y. Yamagata, K. Matsunaga, Y. Minakata, M. Ichinose (Wakayama, Japan)
Source:
Annual Congress 2005 - COPD - treatment II
Session:
COPD - treatment II
Session type:
Thematic Poster Session
Number:
1951
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Hirano, M. Nakanishi, M. Gohda, T. Yamagata, K. Fukui, K. Ueshima, K. Akamatsu, Y. Yamagata, K. Matsunaga, Y. Minakata, M. Ichinose (Wakayama, Japan). Inhibition of reactive nitrogen species production in COPD airways: comparison between steroid and theophylline. Eur Respir J 2005; 26: Suppl. 49, 1951
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Source: Eur Respir J 2004; 23: 496
Year: 2004
Increased production of reactive oxygen species of systemic PMN from COPD patients in comparison to healthy controls
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Apocynin reduces reactive oxygen species generation in airways of asthmatics
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Source: Eur Respir J 2003; 22: 457-461
Year: 2003
Analysis of reactive oxygen species in sputum neutrophils during acute exacerbation of COPD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
LSC 2011 Abstract: Effect of inhaled apocynin on reactive oxygen species concentrations in exhaled breath condensate of asthmatics
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011
Elevated mitochondrial reactive oxygen species in COPD macrophages at exacerbation
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Erdosteine affects eicosanoid production in asthma and COPD
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Altered mitochondrial reactive oxygen species (ROS) production in airway smooth muscle cells of severe asthma.
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Role of complex I and III in the production of reactive oxygen species by mitochondria of peripheral muscle in COPD subjects
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009
Quantitative measurement of RNS production in the airways in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
Hydrogen gas alters the production of reactive oxygen species in alveolar epithelial cells
in vitro
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012
Aerobic exercise reduces airway inflammation, remodeling and hyperresponsiveness by inhibiting reactive oxygen species and TGF-beta production by activated airway leukocytes: a flow cytometry approach
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
Adenosine 5'-monophosphate in asthma: gas exchange and sputum cellular responses
Source: Eur Respir J 2008; 31: 1205-1212
Year: 2008
Reactive oxygen species concentrations are decreased by nebulized apocynin in exhaled breath condensate of healthy subjects
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Reactive oxygen species generation and exhaled nitric oxide in atopic mild bronchial asthma in exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002
Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma
Source: Eur Respir J 2002; 19: 872-878
Year: 2002
Active oxigen species generation by leukocytes in infants with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006
Effect of theophylline on endogenous hydrogen sulfide in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 671s
Year: 2006
Altered reactive oxygen species generation in neutrophils of children with pollinosis
Source: Eur Respir J 2005; 26: Suppl. 49, 589s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept